drugset / Trial / NCT01099891

The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients

NCT01099891

Phase 3 Unknown 300 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this Study is to evaluate the efficacy and safety of rhEGF on oral mucositis in patients receiving the radiation therapy or the concurrent chemo-radiotherapy

Timeline

Start
2010-03
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject NEPIDERMIN Protein / enzyme biologic 50 ug/ml Other

Indications